BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,313 | -22.4% | 285 | -2.4% | 0.00% | – |
| Q2 2023 | $18,454 | +142.7% | 292 | +72.8% | 0.00% | – |
| Q1 2023 | $7,603 | +48.3% | 169 | +44.4% | 0.00% | – |
| Q4 2022 | $5,126 | -60.6% | 117 | -42.1% | 0.00% | – |
| Q3 2022 | $13,000 | 0.0% | 202 | -23.2% | 0.00% | – |
| Q2 2022 | $13,000 | +44.4% | 263 | +89.2% | 0.00% | – |
| Q1 2022 | $9,000 | -18.2% | 139 | +29.9% | 0.00% | – |
| Q4 2021 | $11,000 | +22.2% | 107 | +18.9% | 0.00% | – |
| Q3 2021 | $9,000 | +12.5% | 90 | +2.3% | 0.00% | – |
| Q2 2021 | $8,000 | 0.0% | 88 | +1.1% | 0.00% | – |
| Q1 2021 | $8,000 | -20.0% | 87 | +1.2% | 0.00% | – |
| Q4 2020 | $10,000 | +25.0% | 86 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | +60.0% | 86 | +30.3% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 66 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | – | 66 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |